Form 4 for IRMD IRADIMED CORP
Accepted 2023-06-22 00:00:00 ET · period of report 2023-06-20 · accession 0001415889-23-010149 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-22 | 2023-06-20 | IRMD | GLENN JOHN | CFO | M - OptEx | — | +5,795 | 8,295 | +232% | — |
| D | 2023-06-22 | 2023-06-20 | IRMD | GLENN JOHN | CFO | F - Tax | $47.88 | -1,412 | 6,883 | -17% | -$67.6K |
| D | 2023-06-22 | 2023-06-20 | IRMD | GLENN JOHN | CFO | M - OptEx | $0.00 | -5,795 | 17.4K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-20 | M | A | 5,795 | — | 8,295 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2023-06-20 | F | D | 1,412 | $47.88 | 6,883 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-06-20 | M | D | 5,795 | $0.00 | 17,388 | D | — · 2023-06-20 to — | 5,795 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On June 20, 2022, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on June 20, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. |